Showing results (41-50 of 131) with videos related to
Sort By:
Pageof 14
Pharmacotherapy|February 24, 2001
Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactamT K Jellison, P S Mckinnon, M J RybakAntimicrobial Agents and Chemotherapy|June 1, 1992
Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplaninM J Rybak, E M Bailey, L H WarbasseAntimicrobial Agents and Chemotherapy|August 1, 1991
Clinical evaluation of teicoplanin fluorescence polarization immunoassayM J Rybak, E M Bailey, V N ReddyThe Annals of Pharmacotherapy|October 1, 1993
Enterococcus, an emerging pathogenS A Tailor, E M Bailey, M J RybakAntimicrobial Agents and Chemotherapy|June 1, 1997
Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faeciumR C Mercier, H H Houlihan, M J RybakAntimicrobial Agents and Chemotherapy|September 1, 1993
Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro modelB J McGrath, K C Lamp, M J RybakAntimicrobial Agents and Chemotherapy|May 17, 2001
Activities of newer fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniaeE A Coyle, G W Kaatz, M J RybakPharmacotherapy|November 23, 2001
Rhodococcus equi pneumonia in a patient with human immunodeficiency virus: case report and reviewA L Kwa, V H Tam, M J RybakPageof 14